Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer
2020 · ESMO Open · 46 citations
https://doi.org/10.1136/esmoopen-2020-000753
V
Vincenzo Famiglietti
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
73
Papers
911
Citations
16
h-index
27
i10-index
Vincenzo Famiglietti is an academic researcher. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Genetic factors in colorectal cancer & Lung Cancer Treatments and Mutations. The author has an h-index of 16, co-authored 63 publications.
ORCID: 0000-0002-5959-3838Papers by this author
worksRetrospective Study of Regorafenib Versus TAS-102 Efficacy and Safety in Chemorefractory Metastatic Colorectal Cancer (mCRC) Patients: A Multi-institution Real Life Clinical Data
2021 · Clinical Colorectal Cancer · 22 citations
https://doi.org/10.1016/j.clcc.2021.06.002
Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM)
2022 · ESMO Open · 11 citations
https://doi.org/10.1016/j.esmoop.2022.100567
Additional file 2 of Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19445383
Additional file 3 of Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19445386
Data from Antitumor efficacy of dual blockade with encorafenib plus cetuximab in combination with chemotherapy in human <i>BRAFV600E</i> mutant colorectal cancer.
2024 · 0 citations
https://doi.org/10.1158/1078-0432.c.6618070.v4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat